Antitumour immunity invoked by hepatic arterial infusion of first‐line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow‐up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumour immunity invoked by hepatic arterial infusion of first‐line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow‐up

Published:2020-01-07 Issue:7 Volume:146 Page:2019-2026
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Abrahamsson Hanna¹²,Jensen Benny V.³,Berven Lise L.¹,Nielsen Dorte L.³⁴,Šaltytė Benth Jūratė²⁵,Johansen Jakob S.³,Larsen Finn O.³,Johansen Julia S.³⁴,Ree Anne H.¹²^ORCID

Affiliation:

1. Department of OncologyAkershus University Hospital Lørenskog Norway

2. Institute of Clinical MedicineUniversity of Oslo Oslo Norway

3. Department of OncologyHerlev and Gentofte Hospital Herlev Denmark

4. Institute of Clinical MedicineUniversity of Copenhagen Copenhagen Denmark

5. Health Services Research UnitAkershus University Hospital Lørenskog Norway

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32847

Reference49 articles.

1. Survival after liver resection in metastatic colorectal cancer: review and meta‐analysis of prognostic factors;Kanas GP;Clin Epidemiol,2012

2. Laparoscopic Versus Open Resection for Colorectal Liver Metastases

3. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

4. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

5. Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer—the randomised METIMMOX trial;British Journal of Cancer;2024-04-25

2. Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: A retrospective real-world study;Frontiers in Oncology;2023-01-05

3. Immunogenic Cell Death in Cancer;Interdisciplinary Cancer Research;2023

4. Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer;British Journal of Cancer;2022-10-13

5. Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration;Journal of Inflammation Research;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3